A new value-based care model aims to improve cancer patient outcomes while reducing the total cost of care. The proposal, called OCM 2.0, was developed by The Community Oncology Alliance (COA) and has been submitted to an advisory group of the Department of Health and Human Services (HHS) for review.
“With the OCM 2.0 model, COA seeks to address the most significant obstacle preventing progress in value—the ever-increasing and unsustainable cost of cancer drugs and therapies,”